First Turn Management »

Olema Pharmaceuticals shares owned by First Turn Management

Quarter-by-quarter ownership of Olema Pharmaceuticals (OLMA) shares owned by First Turn Management from 13F filings

Historical chart of First Turn Management investment in Olema Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Olema Pharmaceuticals held by First Turn Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Olema Pharmaceuticals by First Turn Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $15M 618k 25.00

More positions owned by First Turn Management

Abivax Sa Sponsored Ads (ABVX)
Revolution Medicines (RVMD)
Insmed Com Par $.01 (INSM)
Bridgebio Pharma (BBIO)
Mirum Pharmaceuticals (MIRM)
Axsome Therapeutics (AXSM)
Nuvalent Inc-a (NUVL)
Xenon Pharmaceuticals (XENE)
Apogee Therapeutics (APGE)
Terns Pharmaceuticals (TERN)
Newamsterdam Pharma Company Ordinary Shares (NAMS)
United Therapeutics Corporation (UTHR)
Vera Therapeutics Cl A (VERA)
Cogent Biosciences (COGT)
Ascendis Pharma A/s Sponsored Adr (ASND)

View all positions for First Turn Management

Top funds holding Olema Pharmaceuticals

Bain Capital Life Sciences Investors
Paradigm Biocapital Advisors
BlackRock
BVF
Henderson Group
Vanguard Group
Siren
Logos Global Management
Cormorant Asset Management
Franklin Resources
Lightspeed Management Company
State Street Corporation
Vestal Point Capital
Woodline Partners
Polar Capital Holdings

View all funds holding Olema Pharmaceuticals